134276-77-0 Usage
Uses
Used in Cosmetics:
(2S)-3-[(6-O-alpha-D-galactopyranosyl-beta-D-galactopyranosyl)oxy]-2-(tetradecanoyloxy)propyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate is used as an ingredient in cosmetics for its moisturizing and emollient properties due to the presence of fatty acid chains and sugar units.
Used in Pharmaceuticals:
(2S)-3-[(6-O-alpha-D-galactopyranosyl-beta-D-galactopyranosyl)oxy]-2-(tetradecanoyloxy)propyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate is used as a pharmaceutical compound for its potential therapeutic effects, such as anti-inflammatory or antioxidant properties, due to the presence of the sugar units and fatty acid chains.
Used as a Food Additive:
(2S)-3-[(6-O-alpha-D-galactopyranosyl-beta-D-galactopyranosyl)oxy]-2-(tetradecanoyloxy)propyl (9Z,12Z,15Z)-octadeca-9,12,15-trienoate is used as a food additive for its emulsifying and stabilizing properties, which can improve the texture and shelf life of food products.
Check Digit Verification of cas no
The CAS Registry Mumber 134276-77-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,2,7 and 6 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 134276-77:
(8*1)+(7*3)+(6*4)+(5*2)+(4*7)+(3*6)+(2*7)+(1*7)=130
130 % 10 = 0
So 134276-77-0 is a valid CAS Registry Number.
134276-77-0Relevant articles and documents
Synthesis of digalactosyl diacylglycerols and their structure-inhibitory activity on human lanosterol synthase
Tanaka, Rie,Sakano, Yuichi,Nagatsu, Akito,Shibuya, Masaaki,Ebizuka, Yutaka,Goda, Yukihiro
, p. 159 - 162 (2007/10/03)
Digalactosyl and monogalactocyl diacylglycerols, were synthesized. DGDG with two myristoyl groups at both sn-1 and sn-2 positions showed the most potent inhibitory activity on human lanosterol synthase. Digalactosyl and monogalactocyl diacylglycerols (DGDG and MGDG), which were identified as anti-hyperlipemia active components in Colocasia esculenta (Taro), were synthesized. The inhibitory activity of DGDG, MGDG and related compounds on human lanosterol synthase was evaluated as anti-hyperlipemic activity. DGDG with two myristoyl groups at both sn-1 and sn-2 positions and with an oleoyl group at the sn-1 position showed the most potent activity.